Form 8-K - Current report:
SEC Accession No. 0001193125-24-262539
Filing Date
2024-11-20
Accepted
2024-11-20 16:10:00
Documents
14
Period of Report
2024-11-20
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d888285d8k.htm   iXBRL 8-K 24785
2 EX-99.1 d888285dex991.htm EX-99.1 50539
  Complete submission text file 0001193125-24-262539.txt   209970

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sepn-20241120.xsd EX-101.SCH 2516
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE sepn-20241120_lab.xml EX-101.LAB 18701
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sepn-20241120_pre.xml EX-101.PRE 11688
16 EXTRACTED XBRL INSTANCE DOCUMENT d888285d8k_htm.xml XML 3866
Mailing Address 250 EAST GRAND AVENUE, SUITE 65 SOUTH SAN FRANCISCO CA 94080
Business Address 250 EAST GRAND AVENUE, SUITE 65 SOUTH SAN FRANCISCO CA 94080 650-338-3533
Septerna, Inc. (Filer) CIK: 0001984086 (see all company filings)

EIN.: 843891440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42382 | Film No.: 241480450
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)